Skip to main content
Clinical Trials/NCT06770049
NCT06770049
Recruiting
Phase 4

Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial

Mayo Clinic1 site in 1 country228 target enrollmentJanuary 22, 2025
ConditionsObesity

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Obesity
Sponsor
Mayo Clinic
Enrollment
228
Locations
1
Primary Endpoint
Total Body Weight Loss (TBWL)
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

The purpose of this study is to develop an evidence-based precision medicine approach for obesity that enhances weight loss and promotes weight loss maintenance.

Registry
clinicaltrials.gov
Start Date
January 22, 2025
End Date
December 2030
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Andres J. Acosta, M.D., Ph.D.

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Total Body Weight Loss (TBWL)

Time Frame: Baseline, 52 weeks

Change in Total Body Weight Loss (TBWL) in kg

Study Sites (1)

Loading locations...

Similar Trials